Episode Details

Back to Episodes
Pharmaceutical Executive Daily: Nine European Drugmakers Note Concern Over Region's Pharma Investments

Pharmaceutical Executive Daily: Nine European Drugmakers Note Concern Over Region's Pharma Investments

Published 1 month, 3 weeks ago
Description
Nine major European drugmakers warn the region risks losing pharma investment, Novartis licenses a preclinical radioligand therapy asset from BoomRay Pharmaceuticals, and Rafaat Rahmani argues that the costliest competitive intelligence failure is missing the moment a strategic assumption goes wrong.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us